China Renaissance in ‘most challenging period since its establishment’ amid founder’s absence
The investment bank’s revenue fell in the first half as weak demand due to economic uncertainty caused its income from advisory services for private share sales to plunge Key Takeaways:…
FAST NEWS: Hillhouse invests $22 million in Legend Biotech
The latest: Genscript Biotech Corp. (1548.HK) announced on Sunday that its New York-listed subsidiary Legend Biotech Corp. (LEGN.US) has sold 692,782 shares through a private placement to LGN Holdings Ltd.,…
RELATED ARTICLES
-
China Renaissance reborn without rainmaking founder Bao Fan
1911.HK -
China Renaissance Edges Closer to Trading Resumption Under New Chairman
1911.HK
- CHINA BULLETIN: Services, Trade Send Positive Signals
-
Is Youdao finally learning how to earn profits?
DAO.US
-
Goldwind’s profit tumbles as China sales start to deflate
2208.HK 002202.SHE
- CHINA BULLETIN: Manufacturing Déjà Vu
-
Yum China serves up profit, margin growth despite challenging consumer landscape
YUMC.US 9987.HK
